Drug company Merck Ltd on Wednesday posted a 58.37 per cent rise in net profit at Rs 20.05 crore for the fourth quarter ended December 31, 2012 as against a net profit of Rs 12.66 crore for the same period of previous fiscal.
Net sales of the company rose to Rs 161.17 crore for the fourth quarter, as against Rs 126.56 crore during the same period of previous fiscal, Merck said in a BSE filing.
For the year ended December 31, 2012, the company posted a net profit of Rs 78.40 crore against Rs 63.68 crore.
Net sales of the company rose to Rs 658.07 crore for the year ended December 31, 2012, as compared to Rs 557.57 crore in 201.
Shares of Merck closed at Rs 661.35 on the BSE, up 0.91 per cent from their previous close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.